“A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned” has been added to your cart. View cart
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
